Gynecological Devices Market: Global Sales, Ex-factory Price, Revenue, Gross Margin Analysis 2026
Most of the women
worldwide are oblivious to the high risk of dreadful diseases such as
cervical cancer, pelvic pain, uterine fibroids, and vaginitis that
they are susceptible to. The Centers for Disease Control and
Prevention (CDC) runs a National Breast and Cervical Cancer Early
Detection Program (NBCCEDP) that has been running successfully for
over 20 years. The program aims to create awareness and provide women
in the low-income group or those who are uninsured, with regular
breast and cervical cancer screening and diagnostic services. Early
detection is vital in treating such diseases and such initiatives
would propel growth of gynecological imaging devices market.
Increasing prevalence of gynecological diseases would propel demand
for gynecological surgical devices. The Obstetrics and Gynecology
Devices Panel at the Food and Drug Administration (FDA) reviews and
evaluates the safety and effectiveness of investigational and
marketed gynecological devices to ensure patient safety.
Get Exclusive
Sample Report at: http://bit.ly/2YoKxfL
Market Dynamics
Demand for
gynecological devices would increase consequently with increasing
gynecological surgeries. Although drugs are the first line treatment
for a majority of gynecological diseases, surgeries are performed in
severe conditions. Demand for such surgeries and consequently for
devices used for the same are driven majorly by increasing incidence
of gynecological diseases such as cervical cancer, uterine fibroids,
endometriosis, vaginitis and pelvic inflammatory disease (PID). PID
is the second most common and serious complications among the women
in the U.S. According to the Endometriosis UK, 10% of the population
of women worldwide is affected by endometriosis (2016). Global female
population in the age group of 15-64 years increased from 63% in 2010
to 65.6% in 2015 (World Bank). This age group is highly prone to
gynecological problems, owing to changing lifestyle and growing
infection rates. Risk of gynecological problems increases with age.
Female population aged 65 years and above increased exponentially
from 6.8% in 2010 to 8.2% in 2015 (World Bank). Need for
gynecological devices is expected to increase considerably with this
growing aging population. This trend would further propel growth of
the gynecological devices market.
Growing
gynecological procedures and disorders
According to the
Endometriosis UK, 10% of the population of women worldwide is
affected by endometriosis (2016). Moreover, pelvic inflammatory
disease (PID) is the second most common and serious complications
among the women in the U.S. Aging further increases the risk of
cervical cancer, uterine fibroids, and vaginitis. Surgeries are
essential in complex gynecological indications. Being critical and
complex surgical procedures, demand for advance gynecological devices
would increase during the forecast period. This would propel the
growth of gynecological devices market.
Patient safety is
the major point of care for device manufacturers
Certain
gynecological devices such as intra-uterine device (IUD),
morcellators, and vaginal speculums can cause infection and skin
rashes. Several cases of skin rashes and pelvic pain were reported
among women in the U.S. until 2016, who used Essure IUD. The U.S. FDA
therefore asked the manufacturer Bayer, to include a black box
warning on the product pack. Considering their highly personal
application areas, any adverse effects associated with the devices
would severely dent growth prospects of the gynecological devices
market. Advent of robotic surgery is expected to lead to further
innovations in gynecological devices in future. Companies therefore,
need to work closely with surgeons, in order to provide innovative
solutions catering to their specific demands.
Highly populous
emerging economies to be major target markets
Emerging economies
such as India and China are home to over 80% of the global population
(European Central Bank). A large population inadvertently creates a
proportionally large patient pool. Manufacturers of gynecological
devices can potentially target these emerging nations in Asia, Latin
America, Africa and Middle East region for business expansion. Use of
contraceptives is projected to increase in emerging nations with
increasing awareness among the population and initiatives by various
governments to encourage family planning. The Centers for Disease
Control and Prevention (CDC) runs a National Breast and Cervical
Cancer Early Detection Program (NBCCEDP) to create awareness and
provide women in the low-income group or those who are uninsured,
with regular breast and cervical cancer screening and diagnostic
services. Growing awareness initiatives for women population is
creating a demand for early diagnosis of a disease. Improving
healthcare infrastructure would be an effective driver for
gynecological devices market growth. A study published in the Journal
of Mid-Life Health in 2014 concluded that nearly 90% of surgeries in
rural India were conducted without histopathological diagnosis.
However, healthcare investment in India is increasing which is
expected to establish more hospitals and surgical centers thus,
driving growth of the gynecological devices market.
Inquire Here
Before Purchase of Research Report @ http://bit.ly/2FMiboN
Key companies
covered as a part of this study include Ethicon, Inc., Hologic, Inc.,
Stryker Corporation, Cooper Surgical, Inc., Karl Storz GmbH& Co.
KG, Boston Scientific Corporation, and Richard Wolf GmbH.
About Coherent
Market Insights
Coherent Market
Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis,
consulting services, and competitive analysis through various
recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market
Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Comments
Post a Comment